Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: A comparative study

Contraception

Volumn 85, Issue 2, 2012, Pages 173-176

  Oderich, Carolina L ^a   Wender, Maria Celeste O ^a,b   Lubianca, Jaqueline N ^a,b   Santos, Letícia M ^a   De Mello, Grasiele C ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Carbohydrate metabolism; Contraceptive; Copper IUD; Etonogestrel

Indexed keywords

CARBOHYDRATE; COPPER INTRAUTERINE DEVICE; ETONOGESTREL; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG IMPLANT; DRUG RELEASE; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; VAGINA BLEEDING;

ADULT; CARBOHYDRATE METABOLISM; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; FEMALE; HUMANS; INTRAUTERINE DEVICES, COPPER; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855885963     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.05.018     Document Type: Article

References (17)

1. A. Biswas, O.A. Viegas, H.J. Coeling Bennink, T. Korver, and S.S. Ratnam Implanon contraceptive implants: effects on carbohydrate metabolism Contraception 63 2001 137 141 (Pubitemid 32451805)
2. A. Cagnacci, A. Tirelli, M. Cannoletta, D. Pirillo, and A. Volpe Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis Contraception 72 2005 443 446 (Pubitemid 41676835)
3. L.J. Dorflinger Metabolic effects of implantable steroid contraceptives for women Contraception 65 2002 47 62 (Pubitemid 34175238)
4. J. Huber, and R. Wenzl Pharmacokinetics of Implanon. An integrated analysis Contraception 58 1998 85S 90S
5. H.B. Croxatto Mechanisms that explain the contraceptive action of progestin implants for women Contraception 65 2002 21 27 (Pubitemid 34175235)
6. H. Hohmann, and M.D. Creinin The contraceptive implant Clin Obstet Gynecol 50 2007 907 917 (Pubitemid 350059287)
7. S. Funk, M.M. Miller, and D.R. Mishell Jr Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel Contraception 71 2005 319 326 (Pubitemid 40602307)
8. P. Darney, A. Patel, K. Rosen, L.S. Shapiro, and A.M. Kaunitz Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials Fertil Steril 91 2009 1646 1653
9. L. Mäkäräinen, A. van Beek, L. Tuomivaara, B. Asplund, and H.C. Bennink Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant Fertil Steril 69 1998 714 721 (Pubitemid 28188469)
10. Practice Committee of American Society for Reproductive Medicine Hormonal contraception: recent advances and controversies Fertil Steril 90 2008 S103 S113
11. S. Taneepanichskul, D. Reinprayoon, P. Thaithumyanon, P. Praisuwanna, P. Tosukhowong, and T. Dieben Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants Contraception 73 2006 368 371 (Pubitemid 43375097)
12. I. Wiegratz, and H. Kuhl Metabolic and clinical effects of progestogens Eur J Contracept Reprod Health Care 11 2006 153 161 (Pubitemid 44627594)
13. M.M. Inal, Y. Yildirim, K. Ertopcu, M.E. Avci, I. Ozelmas, and S. Tinar Effect of the subdermal contraceptive etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up) Eur J Contracept Reprod Health Care 13 2008 238 242
14. C. Meyer, M. Talbot, and H. Teede Effect of Implanon on insulin resistance in women with polycystic ovary syndrome Aust N Z J Obstet Gynaecol 45 2005 155 158 (Pubitemid 40528563)
15. H.S. Kahn, K.M. Curtis, and P.A. Marchbanks Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk Diabetes Care 26 2003 216 225 (Pubitemid 36929020)
16. G.S. Merki-Feld, B. Imthurn, and B. Seifert Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors Clin Endocrinol (Oxf) 68 2008 355 360 (Pubitemid 351257852)
17. M.E. Gaffield, K.M. Curtis, A.P. Mohllajee, and H.B. Peterson Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant Contraception 73 2006 134 144 (Pubitemid 43087763)